Vijaya Diagnostic Centre Limited (VIJAYA.NS)
INR 1059.9
(-1.03%)
INR 1059.9
(-1.03%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 985.79 Million INR | -38.85% |
| 2022 | 2.8 Billion INR | 16.87% |
| 2021 | 2.39 Billion INR | 17.89% |
| 2020 | 2.03 Billion INR | -3.76% |
| 2019 | 2.11 Billion INR | 15.11% |
| 2018 | 1.83 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 488.64 Million INR | 0.21% |
| 2023 Q1 | 711.13 Million INR | 5.02% |
| 2023 Q4 | 487.59 Million INR | -38.23% |
| 2023 Q3 | 789.39 Million INR | 0.13% |
| 2023 FY | 1.71 Billion INR | -38.85% |
| 2023 Q2 | 788.33 Million INR | 10.86% |
| 2022 Q4 | 677.12 Million INR | -10.26% |
| 2022 FY | 2.8 Billion INR | 16.87% |
| 2022 Q3 | 754.52 Million INR | 5.89% |
| 2022 Q2 | 712.57 Million INR | 8.6% |
| 2022 Q1 | 656.12 Million INR | 0.2% |
| 2021 Q3 | 596.54 Million INR | 3.21% |
| 2021 FY | 2.39 Billion INR | 17.89% |
| 2021 Q4 | 654.83 Million INR | 9.77% |
| 2021 Q2 | 577.98 Million INR | 2.17% |
| 2021 Q1 | 565.71 Million INR | 6.75% |
| 2020 Q3 | 519.83 Million INR | -7.7% |
| 2020 Q1 | 419.42 Million INR | 0.0% |
| 2020 FY | 2.03 Billion INR | -3.76% |
| 2020 Q4 | 529.91 Million INR | 1.94% |
| 2020 Q2 | 563.17 Million INR | 34.28% |
| 2019 FY | 2.11 Billion INR | 15.11% |
| 2018 FY | 1.83 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 1.33 Billion INR | 26.139% |
| Dr. Lal PathLabs Limited | 4.13 Billion INR | 76.161% |
| Metropolis Healthcare Limited | 3.3 Billion INR | 70.137% |
| Thyrocare Technologies Limited | 1.59 Billion INR | 38.345% |
| Vimta Labs Limited | 1.05 Billion INR | 6.783% |